CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
New Poll Shows Strong Bipartisan Support for Children’s Health
Parents are united on key policy priorities for pediatric health care.
Oct. 05, 2026
National Survey Finds Broad Bipartisan Support Among Parents for Federal Action on Children's Health
Likely voters across party lines support investments in pediatric mental health, children’s hospitals, and the pediatric workforce.
Oct. 05, 2026
CHA Responds to Request for Information on Health Care Coverage, Access, and Affordability
The letter urges policymakers to put children at the center of future reforms.
Oct. 02, 2026
